Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the First North 25™ Index, (Nasdaq Stockholm: FN25™), which will become effective at market open on Thursday, January 2, 2025.
The following securities will be added to the lndex: Canatu Oyj A (CANATU), Dala Energi AB (DE), Devyser Diagnostics AB (DVYSR), Faron Pharmaceuticals Oy (FARON), Idun Industrier AB ser. B (IDUN B), Implantica AG SDB ser. A (IMP A SDB), Sveafastigheter AB (SVEAF), and Viva Wine Group AB (VIVA).
The First North 25™ Index measures the performance of a selection of the largest and most traded securities listed on the Nasdaq Nordic First North Growth Markets (First North Denmark, First North Finland, First North Iceland and First North Sweden). The Index is reviewed semi-annually in January and July.
As a result of the semi-annual review, the following securities will be removed from the Index: Cinis Fertilizer AB (CINIS), EXSITEC HOLDING AB (EXS), Genovis AB (GENO), and Haypp Group AB (HAYPP).
For a list of current Index Securities please refer to Nasdaq's Global Index Watch.
For more information, please refer to the First North 25 Index Methodology.
